Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

NCT03413982 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03413982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03413982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Lead sponsor
University of Kansas Medical Center
Phase
Observational
Overall status
Recruiting
Start date
November 2, 2017
Completion date
January 1, 2035
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer